Harvard s Kwiatkowksi Discusses Affy Chips and Atherosclerosis | GenomeWeb

Last week, the Harvard Medical School-Partners Health Care Center for Genetics and Genomics announced that it will embark on a large-scale genotyping study to find genetic risk factors for atherosclerosis. The study will analyze DNA from 1,200 women using Affymetrix’s GeneChip 500K Human Mapping arrays under an early-access program. The samples come from the Women’s Health Study, an ongoing 10-year NIH-funded study of cardiovascular events with 38,000 women participating.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.